All stock lists
Skye Bioscience, Inc. (NASDAQ:SKYE)
US · Delayed Price · Currency is USD
Healthcare · Biotechnology
1.50-0.04 (-2.56%)
Insider Score
––Not scored
SKYE Insider Score
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
SKYE Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Growth (YoY) | — | — | — | — | — | — |
| Cost of Revenue | 0.00 | 172.89 K | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 0.00 | -172.89 K | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A Expense | 3.87 M | 4.74 M | 3.43 M | 3.91 M | 3.91 M | 4.56 M |
| R&D Expense | 3.94 M | 7.76 M | 11.47 M | 9.36 M | 14.34 M | 7.20 M |
| Operating Expenses | 11.06 M | 12.50 M | 14.90 M | 13.26 M | 18.24 M | 11.76 M |
| Operating Income | -11.06 M | -12.67 M | -14.90 M | -13.26 M | -18.24 M | -11.76 M |
| Pretax Income | -10.78 M | -12.51 M | -14.44 M | -12.75 M | -17.62 M | -11.10 M |
| Tax Provision | 3.40 K | 0.00 | 0.00 | 0.00 | 3.40 K | 2.00 K |
| Net Income | -10.79 M | -12.51 M | -14.44 M | -12.75 M | -17.62 M | -11.10 M |
| EPS (Basic) | -2.16 | -2.56 | -2.88 | -2.56 | -3.52 | -2.24 |
| EPS (Diluted) | -2.16 | -2.56 | -2.88 | -2.56 | -3.52 | -2.24 |
| Shares Outstanding | 4.96 M | 4.96 M | 4.96 M | 4.96 M | 4.96 M | 4.96 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.